You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CAVERJECT IMPULSE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Caverject Impulse, and what generic alternatives are available?

Caverject Impulse is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in CAVERJECT IMPULSE is alprostadil. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alprostadil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Caverject Impulse

A generic version of CAVERJECT IMPULSE was approved as alprostadil by HIKMA on January 20th, 1998.

  Try a Trial

US Patents and Regulatory Information for CAVERJECT IMPULSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CAVERJECT IMPULSE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 ⤷  Try a Trial ⤷  Try a Trial
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 ⤷  Try a Trial ⤷  Try a Trial
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 ⤷  Try a Trial ⤷  Try a Trial
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 ⤷  Try a Trial ⤷  Try a Trial
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-002 Jun 11, 2002 ⤷  Try a Trial ⤷  Try a Trial
Pfizer CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CAVERJECT IMPULSE

See the table below for patents covering CAVERJECT IMPULSE around the world.

Country Patent Number Title Estimated Expiration
Norway 952442 ⤷  Try a Trial
Norway 882743 ⤷  Try a Trial
Greece 3035796 ⤷  Try a Trial
Japan H07505553 ⤷  Try a Trial
New Zealand 225181 METHOD AND DEVICE FOR THE PREPARATION OF AN INJECTION SOLUTION ⤷  Try a Trial
Australia 8007694 ⤷  Try a Trial
Mexico 172551 METODO Y APARATO PARA PREPARAR UNA SOLUCION DE INYECCION ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.